Terms of the agreement were not disclosed but Allimax president James Walton, who founded the company in 2002, said: "Tempo is a first-class organization with the critical mass in personnel, sales and tech support, warehousing and complementary product lines that we were searching for as our distributor partner for our flagship brands."
Allisure is a concentrated form of allicin, which has been shown to lower cholesterol and blood pressure and protect against colds and flu, and which may also kill varieties of the hospital superbug MRSA. It is produced from pure, stablised allicin liquid derived from the enzyme allinase and the amino acid alliin found in fresh, raw garlic, which is then spray dried on non-GMO maltodextrin.
Allisure contains the same amount of allicin as 40 whole garlic bulbs.
"A regular garlic pill has a minute amount of allicin compared to one of our pills," said Walton. "Nobody can consume this amount."
In September the company said it was hoping to leverage its science to move out of the crowded garlic supplements segment into a new, higher value 'anti-microbials' category, a term that includes anti-viral, anti-bacterial and anti-fungal action.
Also last year Allimax signed a deal with V-Net Beverage in the US to launch what is thought to be the first functional food or drink containing garlic and which raises the possibility of a range of new products in the US and Europe.